| 000 | 01444 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514043102.0 | ||
| 264 | 0 | _c20021008 | |
| 008 | 200210s 0 0 eng d | ||
| 022 | _a1530-7905 | ||
| 024 | 7 |
_a10.1385/ct:1:4:309 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcHowat, J | |
| 245 | 0 | 0 |
_aOxidant-induced inhibition of myocardial calcium-independent phospholipase A2. _h[electronic resource] |
| 260 |
_bCardiovascular toxicology _c2001 |
||
| 300 |
_a309-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Membrane _xenzymology |
| 650 | 0 | 4 |
_aCytosol _xenzymology |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aGroup VI Phospholipases A2 |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xmetabolism |
| 650 | 0 | 4 |
_aMyocardium _xenzymology |
| 650 | 0 | 4 |
_aNaphthalenes _xtoxicity |
| 650 | 0 | 4 |
_aOxidants _xtoxicity |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPhospholipases A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhospholipases A2 |
| 650 | 0 | 4 |
_aPyrones _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_atert-Butylhydroperoxide _xmetabolism |
| 700 | 1 | _aSwift, L M | |
| 700 | 1 | _aSarvazyan, N | |
| 773 | 0 |
_tCardiovascular toxicology _gvol. 1 _gno. 4 _gp. 309-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1385/ct:1:4:309 _zAvailable from publisher's website |
| 999 |
_c12094700 _d12094700 |
||